Repurposed drug may boost liver transplant success
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,000 new HCC diagnoses per year, and almost 8,000 people affected do not survive the disease. Before the ...
Oct 19, 2022
0
57
Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at ...
Aug 2, 2022
0
72
Treating liver cancer tumors to shrink them in order to allow the patient to qualify for a liver transplant leads to excellent 10-year post-transplant outcomes, according to new Mount Sinai research published in JAMA Surgery. ...
Jul 22, 2022
0
69
Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly ...
Jul 11, 2022
0
62
The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.
Jun 27, 2022
0
120
A national policy change to facilitate the broader sharing of donor livers through "acuity circles" has resulted in procurement delays, according to a researcher at the University of Miami Miller School of Medicine.
May 20, 2022
0
23
Nine young children from Alabama affected by a mysterious hepatitis (inflammation of the liver) all tested positive for a common pathogen called adenovirus 41, a study by the US health agency said Friday.
Apr 30, 2022
0
351
Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver ...
Mar 31, 2022
0
65
Biliary atresia is the largest cause of end-stage liver fibrosis in children and the main reason children need liver transplants. Despite many years of worldwide research, scientists have not yet found a way to prevent the ...
Sep 7, 2021
0
34